This article reviews preclinical evidence on BPC-157’s effects in skeletal muscle injury models, examining signaling pathways involved in myotendinous junction repair, VEGFR2-eNOS angiogenesis, and NO-mediated cytoprotection in rodent crush and ischemia studies.

A research-context review of BPC-157’s role in peripheral nerve and spinal cord injury models, with focus on VEGFR2-ERK1/2-eNOS angiogenic signaling and axonal repair biology.

A review of BPC-157 signaling pathways in corneal and ocular tissue models, focusing on VEGFR2-Akt-eNOS activation, tight junction protein modulation, and preclinical corneal injury findings from rat studies.

An investigation of BPC-157’s observed effects on NLRP3 inflammasome assembly, NF-kB p65 Ser536 phosphorylation, and IL-18 secretion in rodent intestinal epithelial and colitis research models, with analysis of FAK/RhoA tight junction stabilization mechanisms.

A review of preclinical research examining BPC-157’s interactions with gut-brain axis signaling, including vagal afferent pathways, enteric serotonin systems, and corticotropin-releasing factor modulation.

A research-context review of BPC-157’s observed effects on fibroblast activation and connective tissue signaling, examining the plausible role of integrin-mediated cytoskeletal pathways and FAK axis modulation in tendon injury models.

A research-context review of BPC-157’s activation of the Src-Cav-1-eNOS signaling axis, VEGFR2-AKT-driven NO production, and VEGF-mediated angiogenic responses in preclinical ischemia and vascular tissue models.

A research-focused review of BPC-157’s EGF receptor transactivation, ERK1/2 signaling pathway activation, and evidence from preclinical wound re-epithelialization model systems.

A research-context review of BPC-157’s context-dependent nitric oxide synthase modulation, including bidirectional eNOS effects and free radical management in preclinical animal models.